Article: Idenix to present positive results on telbivudine.(American Association for the Study of Liver Diseases)(Idenix Pharmaceuticals Inc. )(Brief Article)

US infectious diseases specialist Idenix Pharmaceuticals says that five abstracts concerning its products have been accepted for presentation at the 56th annual meeting of the American Association for the Study of Liver Diseases, to be held in San Francisco, California, November 11-15, 2005.

One in particular, Telbivudine versus Lamivudine for Chronic Hepatitis B: ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!